US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5474783A
(en)
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5103812A
(en)
*
|
1988-10-12 |
1992-04-14 |
Rochal Industries, Inc. |
Conformable bandage and coating material
|
US5246705A
(en)
*
|
1992-04-08 |
1993-09-21 |
Cygnus Therapeutic System |
Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
|
US5288827A
(en)
*
|
1993-02-17 |
1994-02-22 |
Ciba-Geigy Corporation |
Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
|
GB9411530D0
(en)
*
|
1994-06-09 |
1994-08-03 |
Quayle Rachel A |
Use of polymers as film-forming barrier materials
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
ATE287673T1
(de)
*
|
1995-06-07 |
2005-02-15 |
Southern Biosystems Inc |
Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
|
US6730380B2
(en)
|
1996-02-20 |
2004-05-04 |
Safeskin Corp. |
Readily-donned elastomeric articles
|
US5948400A
(en)
*
|
1997-11-20 |
1999-09-07 |
Smith & Nephew Inc. |
Method of applying a pressure-sensitive adhesive wound dressing and water-based skin treatment composition
|
AU1800099A
(en)
*
|
1997-11-25 |
1999-06-15 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
DE60030542T2
(de)
*
|
1999-03-25 |
2007-06-06 |
3M Innovative Properties Co., Saint Paul |
Nicht stechendes überzugsmittel
|
US6471985B2
(en)
*
|
1999-06-04 |
2002-10-29 |
Bahman Guyuron |
Use of RTV silicone compositions for wound dressing
|
GB0003632D0
(en)
*
|
2000-02-16 |
2000-04-05 |
Univ Hong Kong Science & Techn |
Dimeric compounds
|
US6512072B1
(en)
|
2000-06-12 |
2003-01-28 |
Dow Corning Corporation |
Fast cure film forming formulation
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US6746667B2
(en)
|
2001-07-05 |
2004-06-08 |
Closure Medical Corporation |
Adhesive treatment for tinea pedis
|
US6585967B2
(en)
|
2001-07-05 |
2003-07-01 |
Closure Medical Corporation |
Adhesive treatment for tinea cruris
|
US6942875B2
(en)
*
|
2001-07-05 |
2005-09-13 |
Closure Medical Corporation |
Adhesive treatment for skin yeast infections
|
US6602496B2
(en)
|
2001-07-05 |
2003-08-05 |
Closure Medical Corporation |
Adhesive treatment for tinea corporis
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
WO2004054542A2
(en)
|
2002-12-13 |
2004-07-01 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
US20040122382A1
(en)
*
|
2002-12-23 |
2004-06-24 |
Kimberly-Clark Worldwide, Inc. |
Elastomeric articles with beneficial coating on a surface
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
US20050031817A1
(en)
*
|
2003-08-07 |
2005-02-10 |
Littleton Kermit R. |
Readily donned, powder-free elastomeric article
|
US20050129937A1
(en)
*
|
2003-12-16 |
2005-06-16 |
Eastman Kodak Company |
Antimicrobial web for application to a surface
|
US7842749B2
(en)
*
|
2004-08-02 |
2010-11-30 |
Poly-Med, Inc. |
Tissue protecting spray-on copolymeric film composition
|
US20060030808A1
(en)
*
|
2004-08-09 |
2006-02-09 |
Aso Corporation |
Liquid bandage and tissue sealant
|
ES2602273T3
(es)
|
2004-09-17 |
2017-02-20 |
Durect Corporation |
Composición anestésica local prolongada que contiene Saib
|
US8907026B2
(en)
|
2004-12-23 |
2014-12-09 |
Dow Corning Corporation |
Crosslinkable saccharide-siloxane compositions, and networks, coatings and articles formed therefrom
|
JP4704764B2
(ja)
*
|
2005-02-03 |
2011-06-22 |
日東電工株式会社 |
爪貼付用粘着組成物および爪用貼付剤
|
US7318937B2
(en)
*
|
2005-03-18 |
2008-01-15 |
Closure Medical Corporation |
Liquid coating compositions
|
WO2006127883A2
(en)
|
2005-05-23 |
2006-11-30 |
Dow Corning Corporation |
Personal care compositions comprising saccharide-siloxane copolymers
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
JP5567270B2
(ja)
*
|
2005-08-17 |
2014-08-06 |
ロチャル インダストリーズ エルエルピー |
液体コーティング材料及びキット
|
ES2361857T3
(es)
*
|
2005-12-07 |
2011-06-22 |
Rochal Industries, Llp |
Venda conformable y material de revestimiento.
|
CN101478973B
(zh)
|
2006-05-23 |
2013-08-28 |
陶氏康宁公司 |
用于递送活性成分的新型硅氧烷成膜剂
|
AU2008222638B2
(en)
*
|
2007-03-08 |
2013-10-31 |
Moko Therapeutics Llc |
Dressing formulations to prevent and reduce scarring
|
US8173146B2
(en)
*
|
2007-04-23 |
2012-05-08 |
Safen'Simple LLC |
Stoma wipe and adhesive remover and method
|
US20080302827A1
(en)
*
|
2007-06-06 |
2008-12-11 |
Gerrish Donald L |
Spray dispenser
|
WO2009075782A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
US8852558B2
(en)
*
|
2008-03-11 |
2014-10-07 |
Materials Modification, Inc. |
In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
|
US8828358B2
(en)
*
|
2008-03-11 |
2014-09-09 |
Materials Modifications, Inc. |
In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
|
RU2010151562A
(ru)
|
2008-06-20 |
2012-07-27 |
ВАЙЕТ ЭлЭлСи (US) |
Композиции и способы применения orf1358 из бета-гемолитических стрептококковых штаммов
|
US8003132B2
(en)
|
2008-06-30 |
2011-08-23 |
Johnson & Johnson Consumer Companies, Inc. |
Compositions comprising an ultraviolet radiation-absorbing polymer
|
AR073060A1
(es)
|
2008-08-14 |
2010-10-13 |
Arana Therapeutic Ltd |
Anticuerpos anti-il-12/il-23
|
DE102008048338A1
(de)
|
2008-09-22 |
2010-03-25 |
Beiersdorf Ag |
Wundversorgungszubereitung mit verminderten Hautirritationen
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
DE102008060904A1
(de)
*
|
2008-12-09 |
2010-06-10 |
Beiersdorf Ag |
Wasserlösliche Wirkstoffe in Sprühpflaster
|
US8957277B2
(en)
|
2009-04-27 |
2015-02-17 |
Avery Dennison Corporation |
Disruptable adhesive layer for fluid activated debonding
|
US8946499B2
(en)
|
2009-04-27 |
2015-02-03 |
Avery Dennison Corporation |
Systems, methods and materials for delivery and debonding on demand
|
US8828425B2
(en)
*
|
2010-02-02 |
2014-09-09 |
Poly-Med, Inc. |
In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
|
US8475774B2
(en)
|
2010-02-08 |
2013-07-02 |
Johnson & Johnson Consumer Companies, Inc. |
Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer
|
US8853372B2
(en)
|
2010-08-23 |
2014-10-07 |
Dow Corning Corporation |
Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
|
JP5754665B2
(ja)
*
|
2010-10-22 |
2015-07-29 |
アルケア株式会社 |
皮膚の痛み緩和用皮膜形成組成物
|
AU2012295120A1
(en)
|
2011-08-14 |
2014-02-27 |
Materials Modification, Inc. |
Method and composition for in situ formation of an artificial blockage to control blood loss
|
BR112014007522A2
(pt)
|
2011-09-30 |
2017-04-25 |
3M Innovative Properties Co |
"composição de revestimento conformável e filme conformável"
|
US8263720B1
(en)
*
|
2011-10-05 |
2012-09-11 |
Rochal Industries, Llp |
Sacrificial adhesive coatings
|
EP2773304B1
(de)
|
2011-10-31 |
2016-03-30 |
Avery Dennison Corporation |
Abreissbare klebeschicht für flüssigkeits aktivierte ablösung
|
US9926470B2
(en)
|
2012-10-22 |
2018-03-27 |
Avery Dennison Corporation |
Hybrid material of crosslinked microgel particles dispersed in an adhesive
|
WO2014064703A1
(en)
*
|
2012-10-28 |
2014-05-01 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
ES2962574T3
(es)
|
2012-11-06 |
2024-03-19 |
Rochal Tech Llc |
Administración de agentes biológicamente activos utilizando disolventes volátiles hidrófobos
|
EP2968133A4
(de)
|
2013-03-10 |
2016-03-09 |
Peritech Pharma Ltd |
Topische zusammensetzungen und verfahren zur behandlung von topischen erkrankungen
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US20140272129A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Apple Inc. |
Compliant permeable glue applicator
|
WO2015017044A1
(en)
*
|
2013-07-27 |
2015-02-05 |
Colby Lawrence A |
Systems and methods for enhancing the visibility of medical items
|
US8877882B1
(en)
|
2013-10-04 |
2014-11-04 |
Rochal Industries Llp |
Non-self-adherent coating materials
|
PT3712174T
(pt)
|
2013-12-24 |
2022-05-27 |
Janssen Pharmaceutica Nv |
Anticorpos e fragmentos anti-vista
|
WO2015138175A1
(en)
|
2014-03-10 |
2015-09-17 |
3M Innovative Properties Company |
Conformable coating composition
|
CN107406593A
(zh)
*
|
2014-12-30 |
2017-11-28 |
莫门蒂夫性能材料股份有限公司 |
硅氧烷配位聚合物
|
WO2016153760A1
(en)
|
2015-03-23 |
2016-09-29 |
Clariant Corporation |
A catalyst material for the oxidation and ammoxidation of propylene and isopropylene, processes for making and using same
|
KR20170134572A
(ko)
*
|
2015-04-06 |
2017-12-06 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
제거가능한 필름 형성 겔 조성물 및 이의 적용 방법
|
EP3313882B1
(de)
|
2015-06-24 |
2020-03-11 |
Janssen Pharmaceutica NV |
Anti-vista-antikörper und -fragmente
|
CA3014013A1
(en)
|
2016-02-12 |
2017-08-17 |
Janssen Pharmaceutica Nv |
Anti-vista (b7h5) antibodies
|
CN109071653A
(zh)
|
2016-03-29 |
2018-12-21 |
詹森生物科技公司 |
用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
JP2020500152A
(ja)
|
2016-09-30 |
2020-01-09 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で乾癬を治療する安全かつ有効な方法
|
WO2018071278A1
(en)
*
|
2016-10-13 |
2018-04-19 |
3M Innovative Properties Company |
Removable film-forming gel compositions featuring adhesion promoters
|
EP3541422A4
(de)
|
2016-11-16 |
2020-05-06 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von schuppenflechte mit anti-il-23-spezifischem antikörper
|
DE102017100443A1
(de)
*
|
2017-01-11 |
2018-07-12 |
Madeleine Elixmann |
Flüssigpflaster, Auftragevorrichtung und deren Verwendung
|
MA47362A
(fr)
|
2017-01-30 |
2019-12-04 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif
|
JP2020506947A
(ja)
|
2017-02-07 |
2020-03-05 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
IL276896B2
(en)
|
2018-03-05 |
2024-06-01 |
Janssen Biotech Inc |
Methods for treating Crohn's disease with a specific anti-IL23 antibody
|
EP3824295A4
(de)
|
2018-07-18 |
2022-04-27 |
Janssen Biotech, Inc. |
Prädiktoren mit verzögerter wirkung nach behandlung mit anti-il23-spezifischem antikörper
|
KR20230148273A
(ko)
|
2018-09-24 |
2023-10-24 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체로 궤양성 결장염을 치료하는 안전하고 효과적인 방법
|
CA3120237A1
(en)
|
2018-11-20 |
2020-05-28 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il-23 specific antibody
|
WO2020128864A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and effective method of treating lupus with anti-il12/il23 antibody
|
BR112021013903A2
(pt)
|
2019-01-15 |
2021-09-21 |
Janssen Biotech, Inc. |
Composições e métodos de anticorpos anti-tnf para o tratamento da artrite idiopática juvenil
|
KR20210118878A
(ko)
|
2019-01-23 |
2021-10-01 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료 방법에 사용하기 위한 항-tnf 항체 조성물
|
US20200291107A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions
|
CA3133381A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CN113840837A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的方法
|
JP2022526881A
(ja)
|
2019-03-14 |
2022-05-27 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を産生するための方法
|
BR112021018441A2
(pt)
|
2019-03-18 |
2023-02-28 |
Janssen Biotech Inc |
Método para tratamento de psoríase em indivíduos pediátricos com anticorpo anti-il12/il23
|
BR112021023295A2
(pt)
|
2019-05-23 |
2022-02-08 |
Janssen Biotech Inc |
Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa
|
CN114173873A
(zh)
|
2019-06-03 |
2022-03-11 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
WO2020245676A1
(en)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
CN111450310A
(zh)
*
|
2020-03-03 |
2020-07-28 |
劳龙斯(上海)医药科技有限公司 |
一种新型液体伤口敷料及其制备方法
|
CN111714692B
(zh)
*
|
2020-07-07 |
2022-04-15 |
华熙生物科技股份有限公司 |
一种皮肤创面保护组合物及其制备方法
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
CA3213278A1
(en)
|
2021-03-12 |
2022-09-15 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
AU2022308201A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
IL309987A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Production methods for the production of anti-IL12/IL23 antibody compositions
|
IL309997A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Production methods for the production of anti-TNF antibody compositions
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
IL312778A
(en)
|
2021-11-15 |
2024-07-01 |
Janssen Biotech Inc |
Methods for treating Crohn's disease with a specific anti-IL23 antibody
|
CA3239216A1
(en)
|
2021-11-23 |
2023-06-01 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|
US20230312703A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis with IL-23 Specific Antibody
|
US20230374122A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody
|
US20240199734A1
(en)
|
2022-11-22 |
2024-06-20 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|